The Japanese Journal of Pharmacology · 1982 · 45 citations · 9 references
MedicinePharmacologyClinical PharmacologyExperimental PharmacologyPharmacodynamicsCardiovascular PharmacodynamicsHemodynamic PharmacologyVasoactive Drug TherapyVasoactive MedicationsVasodilator TherapyAntihypertensive Vasodilator TherapyBlood FlowBlood PressureCardiovascular Drug PharmacologyHemodynamic Drug EffectsHemodynamic Effects Of VasodilatorsVasoactive Drug MechanismsVasodilator Pharmacology
Vasodilator and hypotensive effects of (+) and (-) nicardipine were investigated in anesthetized dogs. When administered intravenously, (+) nicardipine was 3 times as potent as the (-) isomer in increasing vertebral blood flow and in lowering mean blood pressure. When injected into the vertebral artery, (+) nicardipine was also 3 times as potent as the (-) isomer in increasing vertebral blood flow. Upon both routes of administration, the duration of the action after (+) nicardipine was longer than that after the (-) isomer. However, there were no differences of plasma nicardipine levels after intravenous injection of both isomers to conscious beagle dogs. The LD50 values of (+) nicardipine in mice and rats upon intravenous injection were only 1.5-2 times smaller than those of the (-) isomer. These results indicate that there exists a stereoselectivity of vasodilator and hypotensive actions among the nicardipine isomers.
9